First-line use of enfuvirtide-containing HAART regimen with dramatic clinical and immunological improvement in three cases.
Bourgarit
Anne
A
Lascoux
Caroline
C
Palmer
Pierre
P
Tuleja
Ewa
E
Pintado
Claire
C
Farge
Dominique
D
Sereni
Daniel
D
D000328:Adult; D023241:Antiretroviral Therapy, Highly Active; D018791:CD4 Lymphocyte Count; D000077560:Enfuvirtide; D015700:HIV Envelope Protein gp41 / Q000627:therapeutic use*; D023581:HIV Fusion Inhibitors / Q000627:therapeutic use*; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010446:Peptide Fragments / Q000627:therapeutic use*; D016896:Treatment Outcome; D019562:Viral Load
D015700:HIV Envelope Protein gp41; D023581:HIV Fusion Inhibitors; D010446:Peptide Fragments; D000077560:Enfuvirtide